Cite

HARVARD Citation

    Solomon, B. et al. (n.d.). 3104 Rociletinib treatment and outcomes in non-small cell lung cancer (NSCLC) patients with negative central testing for T790M. European journal of cancer. pp. S636-. [Online]. 
  
Back to record